<DOC>
	<DOCNO>NCT02640976</DOCNO>
	<brief_summary>The aim study assess role AMH prediction poor ovarian response well relation ESR2 ( +1730G &gt; A ) ( rs4986938 ) , FSHR p.Thr307Ala ( c.919A &gt; G , rs6165 ) FSHR p.Asn680Ser ( c.2039A &gt; G , rs6166 ) SNPs poor response Egyptian woman undergo IVF procedure . Discovering genetic variant associate ovarian response important step towards individualize pharmacogenetic protocol ovarian stimulation .</brief_summary>
	<brief_title>Poor Ovarian Stimulation Response In Vitro Fertilization ( IVF ) Program</brief_title>
	<detailed_description>In-vitro fertilization treatment safety highly challenge erratic individual variability control ovarian hyperstimulation ( COH ) . One diverse predictive factor AMH , consider sensitive marker . Nowadays , practice pharmacogenetics could predict stimulation success thus tailor treatment reach advancement patient care . Since efficiency Follicle stimulate hormone ( FSH ) dose greatly related success COH , FSHR gene treat primary candidate explain difference COH results.Furthermore , estrogen receptor important gene improvement diagnosis treatment infertility . Materials Methods : Starting June 2013 , couple unexplained infertility , seek first attempt IVF/ICSI treatment cycle recruit `` AL shark Al-Awsat fertility center '' .In prospective study , 216 Couples fulfil inclusion criterion enroll study inform consent . Ovarian stimulation perform accord GnRH antagonist protocol fix daily morning dose Human menopausal gonadotrophin ( HMG ) [ Merional® 75 IU ampoule , IBSA institut ] intra-muscular injection start cycle day 2 . Based patient 's body mass index hormonal profile , daily dose HMG adjust ( 225 IU ) participant AMH level &gt; 1.5 ng/ml and/or FSH level ≤ 8 mIU/ml ( 300 IU ) participant AMH level &lt; 1.5 ng/ml and/or FSH level &gt; 8 mIU/ml , dos increase 75 IU case BMI &gt; 30 Kg/m2 . On day 2 menstrual cycle , dose HMG commence patient maintain 9-11 day accord participant individual ovarian response assess trans-vaginal ultrasound folliculometry start cycle day 7 continued every day day Human chorionic gonadotrophin ( hCG ) injection . On cycle day 7 , GnRH antagonist Cetrorelix 0.25 mg [ Cetrotide® 0.25 mg syrinx , Merck Serono ] introduce daily subcutaneous injection continue till day ovulation trigger . Finally , least 3 follicle reach 17 mm diameter , ovulation trigger single intra-muscular injection 10,000 IU hCG [ Choriomon® 5000 IU ampoule , IBSA institut ] . 36 hour later , oocyte retrieval perform guided transvaginal ultrasound . According primary outcome , number oocyte collect , patient classify poor responder ( 4 oocyte less ) consider good responder produce 5 oocyte . The good responder group serve control group . Genotyping : Peripheral blood collect patient EDTA-containing tube . Genomic DNA extract lymphocytes peripheral blood fully automate system QIAcube use QIAamp DNA Blood Mini Kit ( 250 ) plus QIAamp DNA Blood Mini Accessory Set B , cat . . 1043369 . Detection polymorphism ESR2 ( +1730G &gt; A ) ( rs4986938 ) , FSHR p.Thr307Ala ( c.919A &gt; G , rs6165 ) FSHR p.Asn680Ser ( c.2039A &gt; G , rs6166 ) SNPs perform use TaqMan system real-time polymerase chain reaction ( PCR ) . Primers probe provide applied biosystem , Life Technologies . Assays perform TaqMan Universal Master Mix . Statistical analysis : Data statistically describe term mean standard deviation , quantitative data frequency ( number case ) relative frequency ( percentage ) qualitative data . Hardy-Weinberg ( H-W ) Equilibrium polymorphism test use Chi-square test . Comparison quantitative variable do use unpaired test compare 2 category one way analysis variance ( ANOVA ) post hoc test compare 2 category . For compare categorical data , Chi square test perform . Exact test use instead expected frequency less 5 . Genotype allele frequency compare disease control group use chi-square test . Odds ratio ( OR ) 95 % confidence interval calculate . A probability value ( P value ) less 0.05 consider statistically significant . All statistical calculation do use SPSS ( Statistical Package Social Science ; SPSS Inc. , Chicago , IL , USA ) version 22 .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>Women age 35 year . Normal thyroid stimulate hormone prolactin level . Normal ovulatory cycle ( 2535 interval day ) , together proven patent fallopian tube hysterosalpingography laparoscopy do within six cycle precede ICSI cycle . Presence ovaries normal finding assess transvaginal ultrasound laparoscopy . All male partner normal semen analysis accord WHO criteria ( WHO , 2010 ) , do within 6 month precede ICSI cycle Exclusion Criteria Chronic medical disorder diabetes . Previous inadequate response ovulation induction . Polycystic ovary syndrome . Women perform ovarian surgery case endometriosis diagnose laparoscopy suspect ultrasound CA125 assay . Abnormal pelvic pathology congenital anomaly .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>vitro fertilization</keyword>
	<keyword>control ovarian hyperstimulation</keyword>
	<keyword>poor ovarian response</keyword>
	<keyword>estrogen receptor 2 gene polymorphism</keyword>
	<keyword>follicle stimulate hormone receptor gene polymorphism</keyword>
	<keyword>anti-mullerian hormone</keyword>
</DOC>